Company: ARMP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-110383
Chunk: 17

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 4
Chunk 17
---
 Current Report on Form 8-K, filed with the SEC on December 11, 2019).​​​3.7​Articles of Amendment to Articles of Incorporation of the Company (effective March 26, 2020) (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on March 30, 2020).​​​3.8​Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.5 to the Company’s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2019).​​​3.9​Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed with the SEC on December 11, 2019).​​​3.10​Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on February 26, 2020). ​​​4.1​Reference is made to Exhibits 3.1 through 3.10.​​​10.1​Credit and Security Agreement, dated August 11, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 12, 2025).​​​